Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1985 Oct;40(10):768–773. doi: 10.1136/thx.40.10.768

Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes, and interleukin 2 production in sarcoidosis.

E Chailleux, J D Bignon, M A Peyrat, A Godard, J P Soulillou
PMCID: PMC460181  PMID: 3877349

Abstract

To test the possibility that T lymphocyte subset imbalance and interleukin 2 (IL2) play a part in the impairment of cellular immune response in sarcoidosis, the proportion of T lymphocyte subsets in peripheral blood and alveolar lavage fluid from 21 patients with sarcoidosis was studied, monoclonal antibodies OKT3, OKT4, and OKT8 being used. Lectin induced production of IL2 and phytohaemagglutinin (PHA) responsiveness of peripheral blood lymphocytes were investigated. The percentage of both OKT3+ and OKT4+ T lymphocytes was significantly lower in peripheral blood from patients with sarcoidosis than in control subjects (control 63% and 46%), more so in patients with chronic sarcoidosis (44% and 23%) than in patients with recent sarcoidosis (56% and 38%). PHA induced IL2 production from peripheral blood lymphocytes did not differ between patients with sarcoidosis and control subjects. There was a significant positive correlation between PHA responsiveness and the percentage of blood OKT3+ and OKT4+ cells. Peripheral blood lymphocyte PHA responsiveness was decreased only in patients with an OKT4/OKT8 ratio of less than 1.5. Finally, late addition of exogenous IL2 to the culture medium on day 5 increased 3(H)Tdr incorporation by PHA stimulated blasts in peripheral blood lymphocytes from normal subjects, but not from those of patients with sarcoidosis. The data suggest that the impairment of cellular immune response in patients with sarcoidosis could in part reflect a decrease in the percentage of blood T helper lymphocytes and impaired IL2 receptors at the surface of stimulated lymphocytes.

Full text

PDF
768

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Damais C., Riveau G., Parant M., Gerota J., Chedid L. Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative. Int J Immunopharmacol. 1982;4(5):451–462. doi: 10.1016/0192-0561(82)90020-0. [DOI] [PubMed] [Google Scholar]
  2. Daniele R. P., Dauber J. H., Rossman M. D. Immunologic abnormalities in sarcoidosis. Ann Intern Med. 1980 Mar;92(3):406–416. doi: 10.7326/0003-4819-92-3-406. [DOI] [PubMed] [Google Scholar]
  3. Daniele R. P., Rowlands D. T. Antibodies to T cells in sarcoidosis. Ann N Y Acad Sci. 1976;278:88–100. doi: 10.1111/j.1749-6632.1976.tb47019.x. [DOI] [PubMed] [Google Scholar]
  4. Faguet G. B. Cellular immunity in sarcoidosis: evidence for an intrinsic defect of effector cell function. Am Rev Respir Dis. 1978 Jul;118(1):89–96. doi: 10.1164/arrd.1978.118.1.89. [DOI] [PubMed] [Google Scholar]
  5. Faure M., Nicolas J. F., Gaucherand M., Czernielewski J., Mauduit G., Thivolet J. Numeration of T cell subsets in sarcoidosis using monoclonal antibodies: decreased levels of peripheral blood T cells and cells with suppressor T cell phenotype. Dermatologica. 1982 Aug;165(2):88–93. doi: 10.1159/000249925. [DOI] [PubMed] [Google Scholar]
  6. First French workshop on standardization of human IL-2: joint report. Lymphokine Res. 1982;1(4):121–127. [PubMed] [Google Scholar]
  7. Ginns L. C., Goldenheim P. D., Burton R. C., Colvin R. B., Miller L. G., Goldstein G., Hurwitz C., Kazemi H. T-lymphocyte subsets in peripheral blood and lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: analysis by monoclonal antibodies and flow cytometry. Clin Immunol Immunopathol. 1982 Oct;25(1):11–20. doi: 10.1016/0090-1229(82)90160-x. [DOI] [PubMed] [Google Scholar]
  8. Godard A., Naulet J., Peyrat M. A., Vie H., Moreau J. F., Bignon J. D., Soulillou J. P. Preparative two-step purification of human IL-2 by HPLC and hydrophobic affinity chromatography. J Immunol Methods. 1984 May 25;70(2):233–244. doi: 10.1016/0022-1759(84)90188-1. [DOI] [PubMed] [Google Scholar]
  9. Goodwin J. S., DeHoratius R., Israel H., Peake G. T., Messner R. P. Suppressor cell function in sarcoidosis. Ann Intern Med. 1979 Feb;90(2):169–173. doi: 10.7326/0003-4819-90-2-169. [DOI] [PubMed] [Google Scholar]
  10. Hunninghake G. W., Crystal R. G. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest. 1981 Jan;67(1):86–92. doi: 10.1172/JCI110036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hunninghake G. W., Crystal R. G. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med. 1981 Aug 20;305(8):429–434. doi: 10.1056/NEJM198108203050804. [DOI] [PubMed] [Google Scholar]
  12. Hunninghake G. W., Fulmer J. D., Young R. C., Jr, Gadek J. E., Crystal R. G. Localization of the immune response in sarcoidosis. Am Rev Respir Dis. 1979 Jul;120(1):49–57. doi: 10.1164/arrd.1979.120.1.49. [DOI] [PubMed] [Google Scholar]
  13. Hunninghake G. W., Gadek J. E., Young R. C., Jr, Kawanami O., Ferrans V. J., Crystal R. G. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med. 1980 Mar 13;302(11):594–598. doi: 10.1056/NEJM198003133021102. [DOI] [PubMed] [Google Scholar]
  14. Katz P., Haynes B. F., Fauci A. S. Alteration of T-lymphocyte subpopulations in sarcoidosis. Clin Immunol Immunopathol. 1978 Jul;10(3):350–354. doi: 10.1016/0090-1229(78)90192-7. [DOI] [PubMed] [Google Scholar]
  15. Madsen M., Johnsen H. E. A methodological study of E-rosette formation using AET-treated sheep red blood cells. J Immunol Methods. 1979 May 10;27(1):61–74. doi: 10.1016/0022-1759(79)90239-4. [DOI] [PubMed] [Google Scholar]
  16. Mangi R. J., Dwyer J. M., Kantor F. S. The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis. Clin Exp Immunol. 1974 Dec;18(4):519–528. [PMC free article] [PubMed] [Google Scholar]
  17. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med. 1981 Jan;94(1):73–94. doi: 10.7326/0003-4819-94-1-73. [DOI] [PubMed] [Google Scholar]
  18. Pinkston P., Bitterman P. B., Crystal R. G. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med. 1983 Apr 7;308(14):793–800. doi: 10.1056/NEJM198304073081401. [DOI] [PubMed] [Google Scholar]
  19. Reinherz E. L., Kung P. C., Breard J. M., Goldstein G., Schlossman S. F. T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved. J Immunol. 1980 Apr;124(4):1883–1887. [PubMed] [Google Scholar]
  20. Semenzato G., Pezzutto A., Agostini C., Gasparotto G., Cipriani A. Immunoregulation in sarcoidosis. Clin Immunol Immunopathol. 1981 Jun;19(3):416–427. doi: 10.1016/0090-1229(81)90084-2. [DOI] [PubMed] [Google Scholar]
  21. Slade J. D., Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med. 1983 Mar;101(3):479–487. [PubMed] [Google Scholar]
  22. Smith K. A., Lachman L. B., Oppenheim J. J., Favata M. F. The functional relationship of the interleukins. J Exp Med. 1980 Jun 1;151(6):1551–1556. doi: 10.1084/jem.151.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Williams J. D., Smith M. D., Davies B. H. Interaction of immune complexes and T suppressor cells in sarcoidosis. Thorax. 1982 Aug;37(8):602–606. doi: 10.1136/thx.37.8.602. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES